首页> 外文期刊>Environmental Health: A Global Access Science Source >Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study
【24h】

Association between In Utero arsenic exposure, placental gene expression, and infant birth weight: a US birth cohort study

机译:子宫内砷暴露,胎盘基因表达与婴儿出生体重之间的关联:一项美国出生队列研究

获取原文
           

摘要

Background Epidemiologic studies and animal models suggest that in utero arsenic exposure affects fetal health, with a negative association between maternal arsenic ingestion and infant birth weight often observed. However, the molecular mechanisms for this association remain elusive. In the present study, we aimed to increase our understanding of the impact of low-dose arsenic exposure on fetal health by identifying possible arsenic-associated fetal tissue biomarkers in a cohort of pregnant women exposed to arsenic at low levels. Methods Arsenic concentrations were determined from the urine samples of a cohort of 133 pregnant women from New Hampshire. Placental tissue samples collected from enrollees were homogenized and profiled for gene expression across a panel of candidate genes, including known arsenic regulated targets and genes involved in arsenic transport, metabolism, or disease susceptibility. Multivariable adjusted linear regression models were used to examine the relationship of candidate gene expression with arsenic exposure or with birth weight of the baby. Results Placental expression of the arsenic transporter AQP9 was positively associated with maternal urinary arsenic levels during pregnancy (coefficient estimate: 0.25; 95% confidence interval: 0.05 – 0.45). Placental expression of AQP9 related to expression of the phospholipase ENPP2 which was positively associated with infant birth weight (coefficient estimate: 0.28; 95% CI: 0.09 – 0.47). A structural equation model indicated that these genes may mediate arsenic’s effect on infant birth weight (coefficient estimate: -0.009; 95% confidence interval: -0.032 – -0.001; 10,000 replications for bootstrapping). Conclusions We identified the expression of AQP9 as a potential fetal biomarker for arsenic exposure. Further, we identified a positive association between the placental expression of phospholipase ENPP2 and infant birth weight. These findings suggest a path by which arsenic may affect birth outcomes.
机译:背景流行病学研究和动物模型表明,子宫内砷暴露会影响胎儿健康,孕产妇摄入砷与婴儿出生体重之间存在负相关关系。但是,这种关联的分子机制仍然难以捉摸。在本研究中,我们旨在通过确定低剂量砷暴露孕妇队列中可能与砷相关的胎儿组织生物标志物,来增加对低剂量砷暴露对胎儿健康影响的了解。方法从新罕布什尔州133名孕妇的尿液样本中测定砷含量。将从参与者收集的胎盘组织样品进行均质化,并分析其在一组候选基因中的基因表达情况,这些候选基因包括已知的砷调节靶标和涉及砷转运,代谢或疾病易感性的基因。使用多变量调整线性回归模型来检验候选基因表达与砷暴露或婴儿出生体重之间的关系。结果胎盘中砷转运蛋白AQP9的表达与孕妇孕期尿中砷的含量呈正相关(系数估计值:0.25; 95%置信区间:0.05 – 0.45)。 AQP9的胎盘表达与磷脂酶ENPP2的表达有关,磷脂酶ENPP2与婴儿的出生体重呈正相关(系数估计值:0.28; 95%CI:0.09 – 0.47)。结构方程模型表明,这些基因可能介导砷对婴儿出生体重的影响(系数估计:-0.009; 95%置信区间:-0.032--0.001; 10,000次重复自举)。结论我们确定AQP9的表达是砷暴露的潜在胎儿生物标志物。此外,我们发现磷脂酶ENPP2的胎盘表达与婴儿出生体重之间存在正相关。这些发现提示砷可能影响出生结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号